日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development of a J paramyxovirus-based vaccine vector

基于J型副粘病毒的疫苗载体的开发

Wrobel, Elizabeth R; Paton-Smith, Julia; Piotrowski, Caroline; Welch, Stephen R; Karaaslan, Elif; Gingerich, Maria Cristina; Gingerich, Aaron; Li, Zhuo; Spengler, Jessica R; He, Biao

Low-dose VSV-EBOV vaccination provides rapid protection from lethal Ebola virus challenge

低剂量VSV-EBOV疫苗可迅速提供针对致命埃博拉病毒攻击的保护

Marzi, Andrea; Furuyama, Wakako; Griffin, Amanda J; Feldmann, Friederike; Shifflett, Kyle W; Wrobel, Elizabeth R; O'Donnell, Kyle L; Hanley, Patrick W; Feldmann, Heinz

Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.

副流感病毒 5 (PIV5) 载体鼻内 COVID-19 疫苗作为单剂量启动剂和加强剂对抗 SARS-CoV-2 变种的功效

Beavis Ashley C, Li Zhuo, Briggs Kelsey, Gingerich María Cristina, Wrobel Elizabeth R, Najera Maria, An Dong, Orr-Burks Nichole, Murray Jackelyn, Patil Preetish, Huang Jiachen, Mousa Jarrod, Hao Linhui, Hsiang Tien-Ying, Gale Michael Jr, Harvey Stephen B, Tompkins S Mark, Hogan Robert Jeffrey, Lafontaine Eric R, Jin Hong, He Biao

Regulation of host gene expression by J paramyxovirus

J副粘病毒对宿主基因表达的调控

Wrobel, Elizabeth R; Jackson, Jared; Abraham, Mathew; He, Biao

Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.

副流感病毒 5 (PIV5) 载体鼻内 COVID-19 疫苗作为单剂量疫苗和针对 SARS-CoV-2 变种的加强疫苗的功效

Beavis Ashley C, Li Zhuo, Briggs Kelsey, Huertas-Díaz María Cristina, Wrobel Elizabeth R, Najera Maria, An Dong, Orr-Burks Nichole, Murray Jackelyn, Patil Preetish, Huang Jiachen, Mousa Jarrod, Hao Linhui, Hsiang Tien-Ying, Gale Michael Jr, Harvey Stephen B, Tompkins S Mark, Hogan Robert Jeffrey, Lafontaine Eric R, Jin Hong, He Biao